Akademik Veri Yönetim Sistemi
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, cilt.13, sa.10, 2025 (SCI-Expanded, Scopus)
BACKGROUND: Currently, individuals can access unlimited information about health, disease, diagnosis, and treatment methods through video sharing sites. The YouTube platform is also widely used by both commercial and nonprofit institutions and organizations to share health information. OBJECTIVE: This study was conducted to examine videos on the YouTube video platform for pressurized metered-dose inhaler (pMDI) practices in terms of usefulness, reliability, and, quality. METHODS: The descriptive study was conducted in January 2024 by analyzing 96 English-language YouTube videos found using the key term "pressure metered dose inhaler". Two independent observers analyzed the videos based on usefulness, Quality Criteria for Consumer Health Information (DISCERN), the Global Quality Score (GQS), the duration, views, likes, comments, and time since publication (days). RESULTS: It was found that 46.9% of videos were uploaded by health professionals or institutions, 70.8% were very useful, 80.2% had moderate reliability, and 55.2% had good-quality content. Videos uploaded by universities, educational institutions, associations, or health information websites were more useful (P = .029), whereas videos uploaded by pharmaceutical companies had more views (P = .037). The video duration showed significant correlations with usefulness (r = 0.307; P = .002), DISCERN (r = 0.301; P = .003), and GQS (r = 0349; P = .000), whereas the number of views showed significant correlations with DISCERN (r = 0.309; P = .002) and GQS (r = 0.347; P = .001). CONCLUSIONS: The content of pMDI application videos on YouTube was useful, with moderate reliability and good quality. YouTube is a suitable platform for videos on pMDI practices and is advantageous for access to health information. (c) 2025 American Academy of Allergy, Asthma & Immunology (J Allergy Clin Immunol Pract 2025;13:2692-9)